• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

L1210细胞甲氨蝶呤耐药亚系中二氢叶酸还原酶的多态性

Polymorphism of dihydrofolate reductase from a methotrexate-resistant subline of L1210 cells.

作者信息

Duffy T H, Beckman S B, Sato J K, Nagae H, Vitols K S, Huennekens F M

出版信息

Adv Enzyme Regul. 1985;23:3-12. doi: 10.1016/0065-2571(85)90037-8.

DOI:10.1016/0065-2571(85)90037-8
PMID:4072799
Abstract

Dihydrofolate reductase, purified to homogeneity (as judged by sodium dodecyl sulfate-polyacrylamide gel electrophoresis), from a subline of L1210 murine leukemia cells resistant to 10(-6) M methotrexate, was resolved into two principal forms (1 and 2) by polyacrylamide gel electrophoresis at pH 8.3 or isoelectric focusing. In the latter procedure, these forms had pI values of 7.4 and 8.2, respectively; both stained for protein and catalytic activity. Form 1 appears to be a single component, comprising ca. 10% of the total protein and at least 20% of the total catalytic activity. It is also more sensitive to inhibition by MTX, more heat-stable, and less susceptible to activation than form 2. Multiple components of 2 were observed by narrowing the pH range in isoelectric focusing, and further resolution was achieved by urea denaturation. Substrate and inhibitor complexes of 1 and 2, differentiated by polyacrylamide gel electrophoresis or isoelectric focusing, provided information about the ability of the enzyme to undergo conformational changes. Interconversion of 1 with one of the components of 2 may also involve conformational isomerism. These conclusions are consistent with the well-known ability of eukaryotic dihydrofolate reductases to exhibit increased catalytic activity (attributed to transformations to more open conformations) when treated with salts, chaotropes, or cysteine-modifying agents. Treatment of the L1210/R6 enzyme preparation with one of these activating agents, 5,5'-dithiobis(2-nitrobenzoic acid), derivatized both 1 and 2 (changing their pI values to 7.3 and 6.9, respectively) and altered the enzyme such that stoichiometric inhibition for MTX was observed.

摘要

从对10⁻⁶ M甲氨蝶呤具有抗性的L1210小鼠白血病细胞亚系中纯化至同质(通过十二烷基硫酸钠-聚丙烯酰胺凝胶电泳判断)的二氢叶酸还原酶,在pH 8.3下通过聚丙烯酰胺凝胶电泳或等电聚焦被解析为两种主要形式(1和2)。在后者的方法中,这些形式的等电点值分别为7.4和8.2;两者均对蛋白质和催化活性染色。形式1似乎是单一成分,约占总蛋白的10%,至少占总催化活性的20%。它对甲氨蝶呤抑制更敏感,更耐热,并且比形式2更不易被激活。通过在等电聚焦中缩小pH范围观察到形式2的多个成分,并且通过尿素变性实现了进一步的解析。通过聚丙烯酰胺凝胶电泳或等电聚焦区分的1和2的底物和抑制剂复合物提供了有关酶进行构象变化能力的信息。1与2的一种成分之间的相互转化也可能涉及构象异构。这些结论与真核二氢叶酸还原酶在用盐、离液剂或半胱氨酸修饰剂处理时表现出增加的催化活性(归因于转变为更开放的构象)的众所周知的能力一致。用这些激活剂之一5,5'-二硫代双(2-硝基苯甲酸)处理L1210/R6酶制剂,使1和2都衍生化(它们的等电点值分别变为7.3和6.9),并改变了酶,从而观察到对甲氨蝶呤的化学计量抑制。

相似文献

1
Polymorphism of dihydrofolate reductase from a methotrexate-resistant subline of L1210 cells.L1210细胞甲氨蝶呤耐药亚系中二氢叶酸还原酶的多态性
Adv Enzyme Regul. 1985;23:3-12. doi: 10.1016/0065-2571(85)90037-8.
2
L1210 dihydrofolate reductase: activation and enhancement of methotrexate sensitivity.
Adv Enzyme Regul. 1985;24:13-25. doi: 10.1016/0065-2571(85)90067-6.
3
L1210 dihydrofolate reductase. Kinetics and mechanism of activation by various agents.L1210二氢叶酸还原酶。各种试剂激活的动力学及机制。
J Biol Chem. 1987 May 25;262(15):7028-33.
4
Multiple forms of L1210 dihydrofolate reductase differing in affinity for methotrexate.对甲氨蝶呤亲和力不同的多种形式的L1210二氢叶酸还原酶。
Biochem Biophys Res Commun. 1984 Feb 29;119(1):352-8. doi: 10.1016/0006-291x(84)91658-9.
5
Substrate and inhibitor complexes of dihydrofolate reductase from amethopterin-resistant L1210 cells.来自氨甲蝶呤抗性L1210细胞的二氢叶酸还原酶的底物和抑制剂复合物
Arch Biochem Biophys. 1975 Dec;171(2):435-43. doi: 10.1016/0003-9861(75)90052-1.
6
Investigations on the mechanisms of methotrexate resistance in a cisplatin-resistant L1210 murine leukemia cell subline.对顺铂耐药的L1210小鼠白血病细胞亚系中甲氨蝶呤耐药机制的研究。
Cancer Chemother Pharmacol. 1996;37(4):337-42. doi: 10.1007/s002800050394.
7
Immunologic heterogeneity of dihydrofolate reductase from methotrexate sensitive and resistant L1210 leukemia cells.来自甲氨蝶呤敏感和耐药L1210白血病细胞的二氢叶酸还原酶的免疫异质性。
Proc Soc Exp Biol Med. 1985 Oct;180(1):98-102. doi: 10.3181/00379727-180-42149.
8
Properties of dihydrofolate reductase from a methotrexate-resistant subline of human KB cells and comparison with enzyme from KB parent cells and mouse S180 AT/3000 cells.来自人KB细胞甲氨蝶呤抗性亚系的二氢叶酸还原酶的特性及其与KB亲本细胞和小鼠S180 AT/3000细胞的酶的比较。
Mol Pharmacol. 1982 Jan;21(1):231-8.
9
A new fluorescent dihydrofolate reductase probe for studies of methotrexate resistance.一种用于研究甲氨蝶呤耐药性的新型荧光二氢叶酸还原酶探针。
J Biol Chem. 1982 Dec 10;257(23):14162-7.
10
Methotrexate-resistant human promyelocytic leukemia (HL-60) cells express a dihydrofolate reductase with altered properties associated with increased enzyme activity.对甲氨蝶呤耐药的人早幼粒细胞白血病(HL-60)细胞表达一种二氢叶酸还原酶,其性质改变与酶活性增加有关。
Biochem Biophys Res Commun. 1985 Jun 14;129(2):536-45. doi: 10.1016/0006-291x(85)90185-8.